US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

27.200
+0.100+0.37%

Close Nov 4 16:00 ET

27.150
-0.050-0.18%

Post 19:14 ET

12.19BMarket Cap18.13P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-12.20%2.55B

-40.79%1.53B

-49.18%1.23B

-24.04%1.68B

-14.50%2.91B

-11.10%2.59B

-13.39%2.43B

-17.69%2.22B

-Cash and cash equivalents

-18.80%1.76B

-57.33%843M

-72.12%477.01M

-5.56%936.45M

3.09%2.17B

10.28%1.98B

11.01%1.71B

-44.93%991.63M

-Short-term investments

7.29%788.6M

12.56%689.48M

5.54%756.74M

-38.99%747.46M

-43.17%735.01M

-45.30%612.52M

-43.19%717.04M

37.27%1.23B

Receivables

-33.06%23.58M

-42.18%22.23M

0.14%36.65M

8.81%37.91M

-0.34%35.23M

-41.59%38.44M

-46.42%36.6M

-52.60%34.84M

-Other receivables

-33.06%23.58M

-42.18%22.23M

0.14%36.65M

8.81%37.91M

-0.34%35.23M

-41.59%38.44M

-46.42%36.6M

-52.60%34.84M

Other current assets

-77.58%2.29M

9.63%5.01M

-95.80%3.8M

-92.51%6.78M

-84.77%10.22M

-15.18%4.57M

1,265.10%90.52M

911.91%90.52M

Total current assets

-12.68%2.58B

-40.72%1.56B

-50.13%1.27B

-26.19%1.73B

-15.71%2.95B

-11.78%2.63B

-11.23%2.55B

-15.62%2.34B

Non current assets

Goodwill and other intangible assets

----

--0

Investments and advances

6.45%15.05B

1.05%14.57B

6.13%15.1B

-7.80%14.11B

-0.45%14.14B

0.15%14.41B

-2.73%14.23B

2.40%15.3B

Other non current assets

-6.30%27.56M

-83.99%4.49M

-77.99%6.52M

-33.98%20.21M

-11.98%29.41M

624.29%28.03M

614.81%29.63M

578.03%30.61M

Total non current assets

6.42%15.08B

0.89%14.57B

5.96%15.11B

-7.85%14.13B

-0.48%14.17B

0.32%14.44B

-2.59%14.26B

2.50%15.33B

Total assets

3.13%17.66B

-5.52%16.13B

-2.57%16.38B

-10.28%15.86B

-3.49%17.12B

-1.75%17.07B

-4.01%16.81B

-0.34%17.67B

Liabilities

Current liabilities

Payables

2.75%121.96M

-2.17%102.96M

-4.27%98.32M

-5.34%115.34M

-7.39%118.69M

-14.21%105.24M

-9.55%102.71M

-5.05%121.84M

-accounts payable

303.10%23.42M

73.52%11.55M

91.82%15.17M

-15.42%13.63M

-52.29%5.81M

-0.08%6.66M

40.68%7.91M

75.38%16.11M

-Dividends payable

-12.70%98.54M

-7.28%91.41M

-12.29%83.16M

-3.80%101.71M

-2.68%112.88M

-15.02%98.58M

-12.17%94.8M

-11.25%105.73M

Current accrued expenses

3.86%56.25M

-4.58%12.6M

-4.58%51.68M

-4.58%12.6M

0.00%54.16M

0.00%13.2M

-6.13%54.16M

-89.59%13.2M

Current debt and capital lease obligation

----

--999.37M

--998.44M

--997.51M

--996.58M

-Current debt

----

--999.37M

--998.44M

--997.51M

--996.58M

Other current liabilities

--97.49M

--9.02M

-8.27%11.38M

----

--12.4M

----

Current liabilities

-76.48%275.7M

-88.85%124.57M

-86.17%161.38M

-88.69%127.93M

542.92%1.17B

722.01%1.12B

581.33%1.17B

343.68%1.13B

Non current liabilities

Long term debt and capital lease obligation

24.07%7.6B

0.27%6.14B

0.27%6.13B

-13.78%6.13B

-13.78%6.12B

-13.77%6.12B

-13.76%6.11B

-Long term debt

24.07%7.6B

0.27%6.14B

0.27%6.13B

-13.78%6.13B

-13.78%6.12B

-13.77%6.12B

-13.76%6.11B

Derivative product liabilities

----

--9.9M

Other non current liabilities

218.13%27.04M

-73.82%3.22M

-64.00%900K

--11.3M

4.94%8.5M

--12.3M

--2.5M

----

Total non current liabilities

24.34%7.63B

0.12%6.14B

0.24%6.14B

0.29%6.14B

-14.19%6.14B

-13.60%6.14B

-13.74%6.12B

-13.62%6.12B

Total liabilities

8.17%7.9B

-13.58%6.27B

-13.59%6.3B

-13.59%6.27B

-0.33%7.31B

0.21%7.25B

0.29%7.29B

-1.22%7.26B

Shareholders'equity

Share capital

-0.92%108K

0.00%108K

0.93%108K

1.87%109K

1.89%108K

0.94%107K

-common stock

-0.92%108K

0.00%108K

0.93%108K

1.87%109K

1.89%108K

0.94%107K

Retained earnings

5.56%2.38B

9.50%2.43B

28.14%2.52B

-14.78%2.13B

-7.90%2.25B

-0.35%2.22B

-12.88%1.96B

7.93%2.5B

Paid-in capital

1.72%4.1B

8.96%4.07B

9.42%4.01B

10.29%4.01B

12.90%4.03B

5.54%3.74B

4.52%3.67B

5.17%3.63B

Less: Treasury stock

1.22%2.66M

-6.15%2.65M

-6.31%2.63M

-5.88%2.62M

-4.47%2.63M

3.36%2.83M

3.35%2.81M

3.84%2.79M

Gains losses not affecting retained earnings

----

--0

----

--0

-17.75%16.9M

Total stockholders'equity

3.10%6.48B

9.17%6.5B

15.96%6.53B

-0.21%6.14B

4.22%6.28B

3.05%5.95B

-2.57%5.63B

6.20%6.15B

Noncontrolling interests

-7.26%3.28B

-13.04%3.36B

-8.71%3.56B

-19.19%3.45B

-19.38%3.53B

-11.37%3.87B

-12.85%3.9B

-7.17%4.26B

Total equity

-0.63%9.75B

0.42%9.86B

5.87%10.08B

-7.98%9.59B

-5.71%9.81B

-3.15%9.82B

-7.06%9.53B

0.29%10.42B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-12.20%2.55B	-40.79%1.53B	-49.18%1.23B	-49.18%1.23B	-24.04%1.68B	-14.50%2.91B	-11.10%2.59B	-13.39%2.43B	-13.39%2.43B	-17.69%2.22B
-Cash and cash equivalents	-18.80%1.76B	-57.33%843M	-72.12%477.01M	-72.12%477.01M	-5.56%936.45M	3.09%2.17B	10.28%1.98B	11.01%1.71B	11.01%1.71B	-44.93%991.63M
-Short-term investments	7.29%788.6M	12.56%689.48M	5.54%756.74M	5.54%756.74M	-38.99%747.46M	-43.17%735.01M	-45.30%612.52M	-43.19%717.04M	-43.19%717.04M	37.27%1.23B
Receivables	-33.06%23.58M	-42.18%22.23M	0.14%36.65M	0.14%36.65M	8.81%37.91M	-0.34%35.23M	-41.59%38.44M	-46.42%36.6M	-46.42%36.6M	-52.60%34.84M
-Other receivables	-33.06%23.58M	-42.18%22.23M	0.14%36.65M	0.14%36.65M	8.81%37.91M	-0.34%35.23M	-41.59%38.44M	-46.42%36.6M	-46.42%36.6M	-52.60%34.84M
Other current assets	-77.58%2.29M	9.63%5.01M	-95.80%3.8M	-95.80%3.8M	-92.51%6.78M	-84.77%10.22M	-15.18%4.57M	1,265.10%90.52M	1,265.10%90.52M	911.91%90.52M
Total current assets	-12.68%2.58B	-40.72%1.56B	-50.13%1.27B	-50.13%1.27B	-26.19%1.73B	-15.71%2.95B	-11.78%2.63B	-11.23%2.55B	-11.23%2.55B	-15.62%2.34B
Non current assets
Goodwill and other intangible assets	----	----	----	----	----	----	----	----	----	--0
Investments and advances	6.45%15.05B	1.05%14.57B	6.13%15.1B	6.13%15.1B	-7.80%14.11B	-0.45%14.14B	0.15%14.41B	-2.73%14.23B	-2.73%14.23B	2.40%15.3B
Other non current assets	-6.30%27.56M	-83.99%4.49M	-77.99%6.52M	-77.99%6.52M	-33.98%20.21M	-11.98%29.41M	624.29%28.03M	614.81%29.63M	614.81%29.63M	578.03%30.61M
Total non current assets	6.42%15.08B	0.89%14.57B	5.96%15.11B	5.96%15.11B	-7.85%14.13B	-0.48%14.17B	0.32%14.44B	-2.59%14.26B	-2.59%14.26B	2.50%15.33B
Total assets	3.13%17.66B	-5.52%16.13B	-2.57%16.38B	-2.57%16.38B	-10.28%15.86B	-3.49%17.12B	-1.75%17.07B	-4.01%16.81B	-4.01%16.81B	-0.34%17.67B
Liabilities
Current liabilities
Payables	2.75%121.96M	-2.17%102.96M	-4.27%98.32M	-4.27%98.32M	-5.34%115.34M	-7.39%118.69M	-14.21%105.24M	-9.55%102.71M	-9.55%102.71M	-5.05%121.84M
-accounts payable	303.10%23.42M	73.52%11.55M	91.82%15.17M	91.82%15.17M	-15.42%13.63M	-52.29%5.81M	-0.08%6.66M	40.68%7.91M	40.68%7.91M	75.38%16.11M
-Dividends payable	-12.70%98.54M	-7.28%91.41M	-12.29%83.16M	-12.29%83.16M	-3.80%101.71M	-2.68%112.88M	-15.02%98.58M	-12.17%94.8M	-12.17%94.8M	-11.25%105.73M
Current accrued expenses	3.86%56.25M	-4.58%12.6M	-4.58%51.68M	-4.58%51.68M	-4.58%12.6M	0.00%54.16M	0.00%13.2M	-6.13%54.16M	-6.13%54.16M	-89.59%13.2M
Current debt and capital lease obligation	----	----	----	----	----	--999.37M	--998.44M	--997.51M	--997.51M	--996.58M
-Current debt	----	----	----	----	----	--999.37M	--998.44M	--997.51M	--997.51M	--996.58M
Other current liabilities	--97.49M	--9.02M	-8.27%11.38M	-8.27%11.38M	----	----	----	--12.4M	--12.4M	----
Current liabilities	-76.48%275.7M	-88.85%124.57M	-86.17%161.38M	-86.17%161.38M	-88.69%127.93M	542.92%1.17B	722.01%1.12B	581.33%1.17B	581.33%1.17B	343.68%1.13B
Non current liabilities
Long term debt and capital lease obligation	24.07%7.6B	0.27%6.14B	0.27%6.14B	0.27%6.14B	0.27%6.13B	-13.78%6.13B	-13.78%6.12B	-13.77%6.12B	-13.77%6.12B	-13.76%6.11B
-Long term debt	24.07%7.6B	0.27%6.14B	0.27%6.14B	0.27%6.14B	0.27%6.13B	-13.78%6.13B	-13.78%6.12B	-13.77%6.12B	-13.77%6.12B	-13.76%6.11B
Derivative product liabilities	----	----	----	----	----	----	----	----	----	--9.9M
Other non current liabilities	218.13%27.04M	-73.82%3.22M	-64.00%900K	-64.00%900K	--11.3M	4.94%8.5M	--12.3M	--2.5M	--2.5M	----
Total non current liabilities	24.34%7.63B	0.12%6.14B	0.24%6.14B	0.24%6.14B	0.29%6.14B	-14.19%6.14B	-13.60%6.14B	-13.74%6.12B	-13.74%6.12B	-13.62%6.12B
Total liabilities	8.17%7.9B	-13.58%6.27B	-13.59%6.3B	-13.59%6.3B	-13.59%6.27B	-0.33%7.31B	0.21%7.25B	0.29%7.29B	0.29%7.29B	-1.22%7.26B
Shareholders'equity
Share capital	-0.92%108K	0.00%108K	0.93%108K	0.93%108K	0.93%108K	1.87%109K	1.89%108K	0.94%107K	0.94%107K	0.94%107K
-common stock	-0.92%108K	0.00%108K	0.93%108K	0.93%108K	0.93%108K	1.87%109K	1.89%108K	0.94%107K	0.94%107K	0.94%107K
Retained earnings	5.56%2.38B	9.50%2.43B	28.14%2.52B	28.14%2.52B	-14.78%2.13B	-7.90%2.25B	-0.35%2.22B	-12.88%1.96B	-12.88%1.96B	7.93%2.5B
Paid-in capital	1.72%4.1B	8.96%4.07B	9.42%4.01B	9.42%4.01B	10.29%4.01B	12.90%4.03B	5.54%3.74B	4.52%3.67B	4.52%3.67B	5.17%3.63B
Less: Treasury stock	1.22%2.66M	-6.15%2.65M	-6.31%2.63M	-6.31%2.63M	-5.88%2.62M	-4.47%2.63M	3.36%2.83M	3.35%2.81M	3.35%2.81M	3.84%2.79M
Gains losses not affecting retained earnings	----	----	--0	--0	----	----	----	--0	--0	-17.75%16.9M
Total stockholders'equity	3.10%6.48B	9.17%6.5B	15.96%6.53B	15.96%6.53B	-0.21%6.14B	4.22%6.28B	3.05%5.95B	-2.57%5.63B	-2.57%5.63B	6.20%6.15B
Noncontrolling interests	-7.26%3.28B	-13.04%3.36B	-8.71%3.56B	-8.71%3.56B	-19.19%3.45B	-19.38%3.53B	-11.37%3.87B	-12.85%3.9B	-12.85%3.9B	-7.17%4.26B
Total equity	-0.63%9.75B	0.42%9.86B	5.87%10.08B	5.87%10.08B	-7.98%9.59B	-5.71%9.81B	-3.15%9.82B	-7.06%9.53B	-7.06%9.53B	0.29%10.42B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data